ARTELO BIOSCIENCES, INC. financial data

Symbol
ARTL on Nasdaq
Location
Solana Beach, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 53% % -94%
Debt-to-equity 1045% % 9244%
Return On Equity -3399% % -3156%
Return On Assets -297% % -216%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,018,746 shares -37%
Common Stock, Shares, Outstanding 1,555,493 shares -52%
Entity Public Float $4,289,305 USD -24%
Common Stock, Value, Issued $2,000 USD -33%
Weighted Average Number of Shares Outstanding, Diluted 787,000 shares 46%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $7,006,000 USD 24%
General and Administrative Expense $5,424,000 USD 39%
Operating Income (Loss) $12,430,000 USD -30%
Nonoperating Income (Expense) $61,000 USD -115%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $12,491,000 USD -37%
Earnings Per Share, Diluted -20 USD/shares -89%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current $0 USD -100%
Assets, Current $1,827,000 USD -63%
Operating Lease, Right-of-Use Asset $73,000 USD -32%
Intangible Assets, Net (Excluding Goodwill) $2,039,000 USD 0%
Assets $4,267,000 USD -40%
Accrued Liabilities, Current $46,000 USD
Liabilities, Current $4,860,000 USD 597%
Operating Lease, Liability, Noncurrent $40,000 USD -49%
Liabilities $4,900,000 USD 532%
Accumulated Other Comprehensive Income (Loss), Net of Tax $277,000 USD -27%
Retained Earnings (Accumulated Deficit) $58,849,000 USD -27%
Stockholders' Equity Attributable to Parent $633,000 USD -110%
Liabilities and Equity $4,267,000 USD -40%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,597,000 USD 46%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 500,000,000 shares 900%
Common Stock, Shares, Issued 1,555,493 shares -52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,592,000 USD 1.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,720,000 USD -61%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $5,678,000 USD 11%
Operating Lease, Liability $87,000 USD 1350%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,550,000 USD -37%
Operating Lease, Liability, Current $39,000 USD 15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 69,444 shares -83%
Additional Paid in Capital $58,491,000 USD 10%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $111,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%